Retinal Detachment Market Size, Share, and Industry Analysis, By Type (Rhegmatogenous, Tractional, and Exudative), By Product (Instruments and Consumables & Accessories), By Treatment Type (Retinopexy, Cryopexy, Scleral Buckle, and Others), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

The global retinal detachment market is majorly driven by factors such as rising prevalence of eye diseases, technological advancements in ophthalmic surgical instruments, rising geriatric population among others. Retinal detachment is one of the emergency situations in which retina, the thin layer of tissue at the back of the eye, is pulled away from its usual position. Ageing, eye injuries, eye surgery, nearsightedness are some of the factors resulting in the retinal detachment.

• For example, as per CDC (Centers for Disease Control and Prevention) data, an estimated 42 million American individuals are affected by severe loss of vision and cataract is responsible for around 17 million of them.

Retinal Detachment Market Driver

Growing Prevalence of Diabetic Retinopathy among Diabetic Population to Boost Market Growth

High prevalence of diabetic retinopathy and other eye conditions among general population is one of the key factors driving the market growth. Along with that, increasing number of individuals suffering from diabetes mellitus has resulted in growing risk of getting diabetic retinopathy which in turn results in propelling the demand for effective treatments for retinal detachment.

• For instance, as per a study published in November 2023, the prevalence of rhegmatogenous retinal detachment (RRD) was the highest in Europe among world regions. It was 14.52 per 100,000 population in Europe. It was followed by Western pacific region.

Download Free sample to learn more about this report.

According to a research study published by American Academy of Ophthalmology in 2021, the global prevalence of diabetic retinopathy was 22.27% in 2020 and the burden is expected to significantly increase by 2045.

Retinal Detachment Market Restraint

High Costs of Retinal Detachment Surgery to Hinder Market Growth

In spite of the growing incidence of retinal detachment among general population, the high cost of treatment especially surgery is anticipated to limit the market growth to certain extent. The high cost may hamper the adoption of surgical interventions among patients. Additionally, high cost of devices also limit their demand in low and middle income countries.

• For example, as per an article published in Healthline in September 2023, the cost of products and services for retinal detachment surgery is around USD 5,000 to USD 10,000.

Retinal Detachment Market Opportunity

Integration of Robotics in Ophthalmology Creates Lucrative Growth Opportunities for Market Players

In recent years, with the technological advancements, the field of retinal detachment surgeries has been revolutionized. The use of robotic surgery in ophthalmology has resulted in various potential advantages to the currently used techniques. The equipment manufacturers are also focusing on introduction of advanced products to capture the untapped avenues of the market. These technologically advanced products offer high precision & accuracy and better outcomes along with other advantages. This in turn results in higher demand for such advanced products.

• For example, Preceyes B.V. is one of the leading manufacturers of robotic surgical systems. The company introduced Preceyes Robotic Surgical System - a robotic assistant for eye surgery. This product has received CE marking and is commercially available for use.

Segmentation

Key Insights

The report covers the following key insights:

• Reimbursement Scenario, By Key Countries/Regions
• Incidence of Retinal Detachment, By Key Countries
• New Product Launches, By Key Players
• Key Industry Developments (Mergers, Acquisitions, Collaborations)
• Overview: Advancements in Retinal Detachment Devices
• Impact of COVID-19 on the Market

Analysis by Type

Based on type, the global market is categorized into rhegmatogenous, tractional, and exudative.

The rhegmatogenous segment is expected to capture a leading market share during the study period. Rhegmatogenous retinal detachment is more common in geriatric population.

• For instance, according to an article published in June 2022, an estimated incidence of Rhegmatogenous retinal detachment (RRD) was 10 to 18 out of every 100,000 people in the U.S.

Analysis by Product

In terms of product, the global retinal detachment market is segmented into instruments and consumables & accessories.

The instruments segment held a substantial market share in 2023. High cost of these instruments coupled with new product launches by the operating players have majorly contributed to the high share of the segment.

• For example, Alcon Inc. offers several instruments that are used in treatment of retinal detachment. CONSTELLATION Vision System is one those devices used in vitrectomy and combined surgeries.

Analysis by Treatment Type

By treatment type, the global retinal detachment market is segmented into retinopexy, cryopexy, scleral buckle, and others.

The retinoplexy segment is anticipated to grow at a significant CAGR over the study period. The advantages offered by this type such as minimally invasive, non-incisional procedure, high success rate and others have supported the segment growth.

• For instance, as per the study published in National center for Biotechnology Information (NCBI) in March 2018, 15% of retinal detachments in the U.S. were treated with pneumatic retinopexy.

Analysis by End User

As per end user, the market is segmented into hospitals & ASCs, specialty clinics, and others.

The hospitals & ASCs segment recorded a significant market share in 2023. Easy availability of treatment options for retinal detachment through hospitals coupled with availability of contemporary infrastructure and adequate resources have supplemented the segment growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The North America region is estimated to capture a major share of the global market in 2023 and maintain its position throughout the study period. Factors contributing to this include high prevalence of degenerative conditions, high patient pool of diabetes, and higher adoption of retinal detachment treatments among the population among others.

• For instance, according to the Centers for Disease Control and Prevention (CDC), an estimated 9.6 million individuals in the U.S. were living with diabetic retinopathy in 2021.

Europe held the second-largest market share in the global market in 2023. This is due to the presence of well-established as well as emerging players in the region. The European market is poised to witness a noteworthy growth rate in the coming years.

Likewise, the market in the Asia Pacific region is projected to witness the fastest growth in the near future.

This can be attributed to factors such as the high prevalence of diabetes, technological advancements in countries such as Japan and others.

Key Players Covered

The global retinal detachment market is a fragmented marketspace and encompasses various entities such as Inami & CO., Ltd, FCI, Carl Zeiss Meditec AG, and OCULUC among others.

The report includes the profiles of the following key players:

• Inami & CO.,Ltd (Japan)
• Carl Zeiss Meditec AG (Germany)
• Alcon Inc. (Switzerland)
• Bausch & Lomb Incorporated. (Canada)
• OCULUS (U.S.)
• IRIDEX Corporation (U.S.)
• FCI (U.S.)

Key Industry Developments

• In April 2022, Carl Zeiss Meditec AG acquired Katalyst Surgical and Kogent Surgical to further strengthen its position in ophthalmic solution providers’ space.
• In August 2020, Topcon Corporation strengthened its footprints in Asia Pacific region with the opening of a new office in India.